Research will include clinical trial outcomes on the efficacy and safety of Gamifant in the treatment of macrophage activating syndrome, updates on trial details of Vonjo investigating the ...

Research will include clinical trial outcomes on the efficacy and safety of Gamifant in the treatment of macrophage activating syndrome, updates on trial details of Vonjo investigating the ...

Research will include clinical trial outcomes on the efficacy and safety of Gamifant in the treatment of macrophage activating syndrome, updates on trial details of Vonjo investigating the potential ...

Gamifant is the only non-Haematology IP from its strategic portfolio. This Immunology drug accounted for roughly 9% of Q1 revenues and grew by approximately 31% YoY. Their 2025 catalysts include ...